PICALM and Alzheimer disease: PICALM's role in AD pathogenesis is further reinforced by genome‐wide association studies that identified SNPs a mechanism underlying the increased AD risk in PICALM variants' carriers (Harold et al., 2009; Kanatsu et al., 2016).